RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONE

Inclusion Criteria: 1. within a BMI range of 18.0 to 28.0 kg/m2 inclusive; 2. males will either be sterile or agree to use from Check-in until 45 days following Study Completion/Discharge approved methods of contraception 3. able to comprehend and willing to sign an Informed Consent Form (ICF); 4. able to void urine on a daily basis and 1 to 2 bowel movements per day. 5. able to swallow 60 mL of dosing suspension. Exclusion Criteria: 1. history or presence of an abnormal ECG 2. participation in more than 1 other radiolabeled investigational study drug trial within 12 months prior to Check-in. 3. exposure to significant radiation within 12 months prior to Check-in; 4. participation in any other investigational study drug trial 5. use of any prescription medications/products within 14 days prior to Check-in 6. use of any inhibitors or inducers of CYP3A4 taken within 30 days prior to Check-in, including but not limited to drugs listed in Appendix E; 7. receipt of blood products within 2 months prior to Check-in;